Literature DB >> 6213027

Augmented numbers of HLA-DR-positive T lymphocytes in the synovial fluid and synovial tissue of patients with rheumatoid arthritis and juvenile rheumatoid arthritis: in vivo-activated T lymphocytes are potent stimulators in the mixed lymphocyte reaction.

O Førre, J H Dobloug, J B Natvig.   

Abstract

Twenty to 40% of T cells from synovial fluid and synovial tissue and 3-11% of the peripheral blood T lymphocytes from patients with rheumatoid arthritis (RA) and juvenile rheumatoid arthritis (JRA) expressed HLA-DR antigens as detected by monoclonal anti-HLA-DR antibodies in direct immunofluorescence. Synovial fluid and synovial tissue T lymphocytes had a stimulating capacity comparable to that of non-T cells in the allogeneic primary mixed lymphocyte reaction (MLR). The MLR was inhibited by monoclonal anti-HLA-DR antibodies. This is, to our knowledge, the first report on in-vivo-activated T lymphocytes as stimulator cells in MLR. The results suggest that T cells from synovial fluid and synovial tissue are locally activated by stimuli so far unidentified.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6213027     DOI: 10.1111/j.1365-3083.1982.tb00643.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  31 in total

Review 1.  Type 1 and type 2 immune responses in children: their relevance in juvenile arthritis.

Authors:  L R Wedderburn; P Woo
Journal:  Springer Semin Immunopathol       Date:  1999

2.  Proliferative response of synovial fluid and peripheral blood mononuclear cells to arthritogenic and non-arthritogenic microbial antigens and to the 65-kDa mycobacterial heat-shock protein.

Authors:  E Hermann; W J Mayet; A W Lohse; J Grevenstein; K H Meyer zum Büschenfelde; B Fleischer
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

Review 3.  Immunopathogenesis of juvenile rheumatoid arthritis: role of T cells and MHC.

Authors:  L I Sakkas; C D Platsoucas
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

Review 4.  Immunoregulatory T cell subsets and T cell activation in rheumatoid arthritis. A need for analysis on the clonal and molecular level.

Authors:  A Quayle; J Kjeldsen-Kragh; O Førre; K Waalen; M Sioud; C Kalvenes; J B Natvig
Journal:  Springer Semin Immunopathol       Date:  1989

Review 5.  Dendritic cells in rheumatoid inflammation.

Authors:  K Waalen; O Førre; J B Natvig
Journal:  Springer Semin Immunopathol       Date:  1988

6.  Phenotypes and spontaneous cell cytotoxicity of mononuclear cells from patients with seronegative spondyloarthropathies: ankylosing spondylitis, psoriatic arthropathy and pauciarticular juvenile chronic arthritis--analysis of mononuclear cells from peripheral blood, synovial fluid and synovial membranes.

Authors:  J Thoen; O Førre; K Waalen; J Pahle
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

7.  Immune function in severe, active rheumatoid arthritis. A relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics.

Authors:  D G Malone; S M Wahl; M Tsokos; H Cattell; J L Decker; R L Wilder
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

Review 8.  Role of endothelium in chronic inflammation.

Authors:  M Ziff
Journal:  Springer Semin Immunopathol       Date:  1989

9.  Local synthesis of both macrophage and T cell cytokines by synovial fluid cells from children with juvenile rheumatoid arthritis.

Authors:  B A Eberhard; R M Laxer; U Andersson; E D Silverman
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

10.  The tissue architecture of synovial membranes in inflammatory and non-inflammatory joint diseases. II. The localization of mononuclear cells as detected by monoclonal antibodies directed against T-lymphocyte subsets and natural killer cells.

Authors:  B Koch; P Locher; G R Burmester; W Mohr; J R Kalden
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.